Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Inventory Average (2020 - 2025)

Harmony Biosciences Holdings' Inventory Average history spans 6 years, with the latest figure at $6.2 million for Q4 2025.

  • For Q4 2025, Inventory Average fell 12.12% year-over-year to $6.2 million; the TTM value through Dec 2025 reached $6.2 million, down 12.12%, while the annual FY2025 figure was $6.3 million, 0.05% changed from the prior year.
  • Inventory Average for Q4 2025 was $6.2 million at Harmony Biosciences Holdings, down from $6.7 million in the prior quarter.
  • Across five years, Inventory Average topped out at $7.1 million in Q4 2024 and bottomed at $4.1 million in Q1 2021.
  • The 5-year median for Inventory Average is $4.9 million (2021), against an average of $5.3 million.
  • The largest annual shift saw Inventory Average skyrocketed 50.59% in 2021 before it dropped 12.29% in 2022.
  • A 5-year view of Inventory Average shows it stood at $4.6 million in 2021, then fell by 4.56% to $4.4 million in 2022, then rose by 18.53% to $5.2 million in 2023, then skyrocketed by 35.05% to $7.1 million in 2024, then fell by 12.12% to $6.2 million in 2025.
  • Per Business Quant, the three most recent readings for HRMY's Inventory Average are $6.2 million (Q4 2025), $6.7 million (Q3 2025), and $6.3 million (Q2 2025).